Compass Cannabis

Over the past two decades, our partners have studied tens of thousands of different cannabis plants to discover genetic variations which are truly unique. They consider market measurables of THC & CBD content, flavor profiles, and yields, as we hunt for the perfect combination to use in cloning and breeding for our seed stock. With careful study of the aromatics of the plant and its colors, the density of the trichomes, cannabinoids, terpenes, and flavonoids, along with plant vigor and pathogen resistance, we then selectively determine which plants ultimately become part of our cultivar library. By aggressively studying phenotype, chemotype, and genotype, we are able to consistently supply the cannabis growers market with strains that consistently outperform the competition at retail. As VP of Business Development for Compass, my responsibilities include forging new partnerships with cannabis operators in international markets focusing on Mexico and multiple Latin American countries. We are continually expanding our genetics partner portfolio. Please reach out to learn more about how we can support your R&D initiatives. Proud Member of the NY Cannabis Growers and Processors Association.